Clinical Trial Update: A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

View source ↗

Summary

This clinical trial update reports that Takeda’s LIVTENCITY (maribavir) is being studied in adults with cytomegalovirus infection after transplantation in South…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• LIVTENCITY (MARIBAVIR)

Snippet

Sponsor: Takeda | Conditions: Cytomegalovirus (CMV) | Status: RECRUITING